Post-approval studies (Phase 4)Ended earlyNCT04705337
What this trial is testing
Levosimendan In Ambulatory Heart Failure Patients
Who this might be right for
Heart Failure New York Heart Association Class IIIHeart Failure New York Heart Association Class IVHeart Failure, Systolic+1 more
Medical University of Bialystok 70